Vergoeding 2017-2021 voor ATC-subgroep R03BB : Parasympathicolytica
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| R03BB01 Ipratropium (Atrovent ®) | 3.399.100 | 3.224.300 | 3.040.900 | 2.920.200 | 2.635.200 |
| R03BB04 Tiotropium (Spiriva ®) | 72.637.400 | 64.080.400 | 59.103.400 | 55.157.900 | 39.004.800 |
| R03BB05 Aclidiniumbromide (Eklira ®) | 1.437.100 | 1.375.100 | 1.253.500 | 1.190.800 | 1.098.700 |
| R03BB06 Glycopyrroniumbromide (Seebri breezhaler ®) | 2.379.400 | 2.101.800 | 1.821.800 | 1.573.600 | 1.217.800 |
| R03BB07 Umeclidiniumbromide (Incruse ellipta ®) | 505.850 | 649.030 | 689.650 | 773.830 | 1.959.300 |
| Totaal | 80.358.850 | 71.430.630 | 65.909.250 | 61.616.330 | 45.915.800 |